Pharmacogenetic vs. Concentration-Controlled Optimization of Tacrolimus Dosing in Renal Allograft Recipients

被引：8
|
作者：
Kuypers, D. R. J. [1 ]
机构：
[1] Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, Louvain, Belgium
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 88卷 / 05期
关键词：
D O I：
10.1038/clpt.2010.129
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：595 / 596
页数：2
相关论文
共 50 条
  • [21] Renal function at month 6 is similar with immediate vs. delayed tacrolimus administration in elderly renal transplant recipients
    Belmonte, Amado Andres
    TRANSPLANT INTERNATIONAL, 2007, 20 : 26 - 27
  • [22] Potential cardiovascular risk factors in pediatric renal transplant recipients: Cyclosporin vs. tacrolimus.
    Ferraris, JR
    Ghezzi, L
    Waisman, G
    Krmar, RT
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 103 - 103
  • [23] Standard dosing of tacrolimus leads to overexposure in pediatric renal transplantation recipients
    Kausman, Joshua Y.
    Patel, Bhumik
    Marks, Stephen D.
    PEDIATRIC TRANSPLANTATION, 2008, 12 (03) : 329 - 335
  • [24] A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients
    Baboolal, K
    TRANSPLANTATION, 2003, 75 (08) : 1404 - 1408
  • [25] LITHIUM DOSING IN RENAL-ALLOGRAFT RECIPIENTS WITH CHANGING RENAL-FUNCTION
    KOECHELER, JA
    CANAFAX, DM
    SIMMONS, RL
    NAJARIAN, JS
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (7-8): : 623 - 624
  • [26] TACROLIMUS DOSING IN RENAL TRANSPLANT RECIPIENTS FOLLOWING INTRODUCTION OF A GENERIC PREPARATION
    Storey, Rowland
    Hossain, Mohammad A.
    Shrivastava, Seema
    Popoola, Joyce
    Heap, Sarah
    MacPhee, Iain
    TRANSPLANT INTERNATIONAL, 2013, 26 : 82 - 82
  • [27] Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients
    Rostaing, L
    Puyoo, O
    Tkaczuk, J
    Peres, C
    Rouzaud, A
    Cisterne, JM
    de Preval, C
    Ohayon, E
    Durand, D
    Abbal, M
    CLINICAL TRANSPLANTATION, 1999, 13 (05) : 400 - 409
  • [28] EFFICACY AND SAFETY OF 24 MONTHS IMMUNOSUPPRESSION WITH CONCENTRATION-CONTROLLED EVEROLIMUS AND REDUCED CYCLOSPORINE IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Yaqoob, M.
    Riad, H.
    Pattison, J.
    Cornu-Artis, C.
    Wang, Z.
    Tedesco Silva, H.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 39 - 39
  • [29] Differential pharmacokinetic interaction of cyclosporine and tacrolimus with colchicine in renal allograft recipients
    Beaudreuil, S.
    Becquemont, L.
    Schermann, J. M.
    Verstuyft, C.
    Barrail-Tran, A.
    Smirnova, M.
    Durrbach, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 68 - 68
  • [30] Differential pharmacokinetic interaction of cyclosporine and tacrolimus with colchicine in renal allograft recipients
    Beaudreuil, Severine
    Schermann, Jean Michel
    Verstuyft, Celine
    Barrail-Tran, Aurelie
    Smirnova, Maria
    Durrbach, Antoine
    Becquemont, Laurent
    CLINICAL TRANSPLANTATION, 2018, 32 (11)
12345